Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.42 |
| ▸ | L3MBTL3 | Q96JM7 | 4/20 | 0.42 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4459484 | 0.99 | SLC6A3 (0.44) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| SCHEMBL4459064 | 0.74 | HRH3 (0.47) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| SCHEMBL4459491 | 0.72 | HRH3 (0.44) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| SCHEMBL4462970 | 0.72 | HRH3 (0.44) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| SCHEMBL2762024 | 0.69 | HRH3 (0.71) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| SCHEMBL2761916 | 0.69 | HRH3 (0.71) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL916318 | 0.67 | HRH3 (0.69) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL9034274 | 0.67 | HRH3 (0.69) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| SCHEMBL1877934 | 0.67 | HRH3 (0.68) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 | |
| SCHEMBL11589061 | 0.65 | SIGMAR1 (1.00) | HRH3SIGMAR1CYP1A2CYP3A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009017838-A2 | COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS | EXELIXIS, INC. (US) | 2009-02-05 | — | — | WO | disclosed |